Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123096) titled 'Clinical Validation of Remimazolam Target-Controlled Infusion System' on April 21.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Shanghai Chest Hospital
Condition:
None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-30
Target Sample Size: Remimazolam group:20;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=319781
Disclaimer: Curated by HT Syndication....